SPL — Starpharma Holdings Income Statement
0.000.00%
Last trade - 00:00- AU$115.01m
- AU$102.01m
- AU$5.85m
- 17
- 21
- 85
- 35
Annual income statement for Starpharma Holdings, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.15 | 4.9 | 4.21 | 9.76 | 5.85 |
| Cost of Revenue | |||||
| Gross Profit | 1.36 | 2.12 | 3.09 | 9.12 | 4.63 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 23.2 | 21.3 | 20 | 17.9 | 15.8 |
| Operating Profit | -21.1 | -16.4 | -15.8 | -8.16 | -9.99 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.7 | -16.2 | -15.6 | -8.16 | -9.99 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.7 | -16.2 | -15.6 | -8.16 | -9.99 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.7 | -16.2 | -15.6 | -8.16 | -9.99 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.7 | -16.2 | -15.6 | -8.16 | -9.99 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.05 | -0.04 | -0.038 | -0.02 | -0.024 |